A 54-year-old patient presented for evaluation of spontaneous left breast discharge. The patient is status post-right mastectomy with TRAM reconstruction in 1999. The patient states she has noted left breast discharge for quite some time.
A 54-year-old patient presented for evaluation of spontaneous left breast discharge. The patient is status post-right mastectomy with TRAM reconstruction in 1999. The patient states she has noted left breast discharge for quite some time.
Mammography reveals postsurgical changes from TRAM reconstruction in the right breast. The left breast reveals no abnormality (Figures 1A and 1B).
Upon examination, discharge was expressed from two ducts in the left breast. In the central portion of the left nipple, a brownish discharge at 12 o’clock was present and, in addition, a clear discharge in the left 6 o’clock portion of the nipple. Slides were obtained and sent for pathology.
A left ductogram was performed; the left breast duct in the 12 o’clock area of the nipple was cannulated centrally and the duct opacified with contrast (Figure 2A and 2B). This revealed multiple areas of intraluminal masses throughout the ductal system (Figure 2C).
Breast MRI for extent of disease revealed extensive diffuse enhancement involving the entire breast (Figure 3). This enhancement extends from the nipple to the chest wall.
Pathology of the left nipple discharge revealed atypical ductal epithelium. Stereotactic core biopsy of the ductographic abnormalities was also performed. Pathology revealed ductal carcinoma in situ, nuclear grade 3.
This case demonstrates the importance of a complete work-up when a patient presents with discharge, including mammography and ductography. In this case, the mammogram was unremarkable; the ductogram revealed multiple intraluminal masses, which upon biopsy proved to be carcinoma. Dr. Destounis is managing partner and a radiologist at Elizabeth Wende Breast Care in Rochester, NY.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
Study Emphasizes PSMA PET Staging of High-Risk, Hormone Sensitive Prostate Cancer
January 4th 2025In patients with high-risk, hormone sensitive prostate cancer who had no evidence of metastasis on conventional imaging, PSMA PET revealed polymetastatic disease in 24 percent of patients and M1 disease staging in 46 percent of patients.
Can MRI and Micro-Ultrasound Guidance Bolster Focal Laser Ablation Outcomes for Prostate Cancer?
January 3rd 2025For patients with localized prostate cancer and PI-RADS 3 or higher lesions, MRI-guided micro-ultrasound multifiber focal laser ablation had an 18 percent recurrence rate at one year, according to newly published research.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.